Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2017

Jun 8, 2017

34975_dirs_2017-06-08_f132701d-f307-49e9-87d4-1bb32b49ff86.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2017-05-18

Reporting Person: LEWIS EARL R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-05-18 Common Stock D 9200 $0.00 Disposed 467350 Direct

Footnotes

F1: The subject restricted stock units were granted to the reporting person on January 3, 2017 and were forfeited as a result of the reporting person stepping down from his roles as Chairman of the Board of Directors, Chairman and Member of the Governance Committee, and Member of the Compensation Committee of the Issuer.

F2: Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 9,450 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (c) 426,600 shares of common stock held by the Reporting Person.